Correlation Between Bristol Myers and Merck

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Merck Company, you can compare the effects of market volatilities on Bristol Myers and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Merck.

Diversification Opportunities for Bristol Myers and Merck

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol and Merck is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Bristol Myers i.e., Bristol Myers and Merck go up and down completely randomly.

Pair Corralation between Bristol Myers and Merck

Assuming the 90 days trading horizon Bristol Myers Squibb is expected to generate 1.28 times more return on investment than Merck. However, Bristol Myers is 1.28 times more volatile than Merck Company. It trades about 0.19 of its potential returns per unit of risk. Merck Company is currently generating about -0.02 per unit of risk. If you would invest  72,578  in Bristol Myers Squibb on September 2, 2024 and sell it today you would earn a total of  49,622  from holding Bristol Myers Squibb or generate 68.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.21%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Merck Company

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward-looking signals remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Bristol Myers and Merck Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Merck

The main advantage of trading using opposite Bristol Myers and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.
The idea behind Bristol Myers Squibb and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges